Evidence against increased glycoxidation in patients with Alzheimer's disease

Neuroscience Letters

Volumn 232, Issue 1, 1997, Pages 49-52

  Seidl, Rainer ^a   Schuller, Elisabeth ^a   Cairns, Nigel ^b   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Choline acetyltransferase; Down syndrome; Glycation; Oxidation

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; GLUCOSE OXIDATION; HUMAN; HUMAN TISSUE; MALE; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINE O-ACETYLTRANSFERASE; DOWN SYNDROME; FEMALE; FRONTAL LOBE; GLYCOSYLATION; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; OXIDATION-REDUCTION;

EID: 0030763372     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00576-4     Document Type: Article

References (28)

1. Baird, P.A. and Sadovnick, A.D., Life expectancy in Down syndrome, J. Pediatr., 110 (1987) 849-854.
2. Dyer, D.G., Dunn, J.A., Thorpe, S.R., Bailie, K.E., Lyons, T.J., McCance, D.R. and Baynes, J.W., Accumulation of Maillard reaction products in skin collagen in diabetes and aging, J. Clin. Invest., 91 (1993) 2463-2469.
3. Fonnum, F., Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities, Biochem. J., 115 (1969) 465-472.
4. Friedlich, A.L. and Butcher, L.L., Involvement of free oxygen radicals in β-amyloidosis: an hypothesis, Neurobiol. Aging, 15 (1994) 443-455.
5. Grundke-Iqbal, I., Iqbal, K., Tung, Y.C., Quinlan, M., Wisniewski, H.M. and Binder, L.I., Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology, Proc. Natl. Acad. Sci. USA, 83 (1986) 4913-4917.
6. Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y.C., Zaidi, M.S. and Wisniwski, H.M., Microtubule-associated protein tau. A component of Alzheimer paired helical filaments, J. Biol. Chem., 261 (1986) 6084-6089.
7. Harrington, C.R. and Colaco, C.A.L.S., Alzheimer's disease, a glycation connection, Nature, 370 (1994) 247-248.
8. Hensley, K., Carney, J.M., Matson, M.P., Aksenova, M., Harris, M., Wu, J.F., Floyd, R.A. and Butterfield, D.A., A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease, Proc. Natl. Acad. Sci. USA, 91 (1994) 3270-3274.
9. Ledesma, M.D., Bonay, P., Colaco, C. and Avila, J., Analysis of microtubule-associated protein tau glycation in paired helical filaments, J. Biol. Chem., 269 (1994) 21614-21619.
10. Liardon, R., Weck-Gaudard, D., Philippossian, G. and Finol, P.A., Identification of N-∈-carboxymethyllysine, a new Maillard reaction product, in rat, J. Agric. Food Chem., 35 (1987) 427-431.
11. Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M. and Crain, B.J., The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardisation of the neuropathological assessment of Alzheimer's disease, Neurology, 41 (1991) 479-486.
12. Monnier, V.M. and Cerami, A., Nonenzymatic browning in vivo: possible process for aging of long-lived proteins, Science, 211 (1981) 491-493.
13. Monnier, V.M., Glomb, M., Elgawish, A. and Sell, D.R., The mechanism of collagen cross-linking in diabetes, a puzzle nearing resolution, Diabetes, 45(Suppl. 3) (1996) S67-S72.
14. Prinsze, C., Dubbelman, T.M. and Van Steveninck, J., Protein damage induced by amounts of photodynamically generated singlet oxygen or hydroxyl radicals, Biochim. Biophys. Acta, 1038 (1990) 152-157.
15. Sell, D.R., Lapolla, A., Odetti, P., Fogarty, J. and Monnier, V.M., Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM, Diabetes, 41 (1992) 1286-1292.
16. Sell, D.R., Lane, M.A., Johnson, W.A., Masoro, E.J., Mock, O.B., Reiser, K.M., Fogarty, J.F., Cutler, R.G., Ingram, D.K., Roth, G.S. and Monnier, V.M., Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence, Proc. Natl. Acad. Sci. USA, 93 (1996) 485-490.
17. Smith, M.A., Taneda, S., Richey, P.L., Miyata, S., Yan, S.-D., Stern, D., Sayre, L.M., Monnier, V.M. and Perry, G., Advanced Maillard reaction end products are associated with Alzheimer disease pathology, Proc. Natl. Acad. Sci. USA, 91 (1994) 5710-5714.
18. Smith, M.A., Sayre, L.M., Monnier, V.M. and Perry, G., Radical AGEing in Alzheimer's disease, Trends Neurosci., 18 (1995) 172-176.
19. Smith, M.A., Perry, G., Richey, P.L., Sayre, L.M., Anderson, V.E., Beal, M. and Kowall, N., Oxidative damage in Alzheimer's disease, Nature, 382 (1996) 120-121.
20. Terry, R.D., Katzman, R. and Bick, K.L., Alzheimer Disease, Raven Press, New York, 1994.
21. Tierney, M.C., Fisher, R.H., Lewis, A.J., Torzitto, M.L., Snow, W.G., Reid, D.W., Nieuwstraten, P., Van Rooijen, L.A.A., Derks, H.J.G.M., Van Wijk, R. and Bischop, A., The NINCDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease, Neurology, 38 (1988) 359-364.
22. Vitek, M.P., Bhattacharya, K., Glendening, J.M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K. and Cerami, A., Advanced glycation end products contribute to amyloidosis in Alzheimer disease, Proc. Natl. Acad. Sci. USA, 91 (1994) 4766-4770.
23. Wells-Knecht, M.C., Thorpe, S.R. and Baynes, J.W., Pathways of formation of glycoxidation products during glycation of collagen, Biochemistry, 34 (1995) 15134-15141.
24. Wisniewski, K.E., Wisniewski, H.M. and Wen, G.Y., Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down syndrome, Ann. Neurol., 17 (1985) 278-282.
25. Wolff, S.P., Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes and complications, Br. Med. Bull., 49 (1993) 642-652.
26. Yan, S.-D., Chen, X., Schmidt, A.-M., Brett, J., Godman, G., Zou, Y.-S., Scott, C.W., Caputo, C., Frappier, T., Smith, M.A., Perry, G., Yen, S.-H. and Stern, D., Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress, Proc. Natl. Acad. Sci. USA, 91 (1994) 7787-7791.
27. Yan, S.-D., Schmidt, A.M., Anderson, G.M., Zhang, J., Brett, J., Zou, Y.S., Pinsky, D. and Stern, D., Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins, J. Biol. Chem., 269 (1994) 9889-9897.
28. Yan, S.-D., Yan, S.-F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M.A., Perry, G., Godman, C., Nawroth, P., Zweier, J.L. and Stern, D., Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide, Nature Med., 1 (1995) 693-699.